Shanghai Jiuchuan Investment Group to acquire Israeli company SHL Telemedicine Ltd
Shanghai Jiuchuan will pay $130 million for 100% of SHL Telemedicine's shares.
Israeli SHL Telemedicine Ltd. (SIX: SHLTN) announced today that Shanghai Jiuchuan investment group of China is to acquire the entire share capital of SHL for $130 million.
Shanghai Jiuchuan is a privately held investment company with a wide variety of interests, including in medicine (technology, services, and IT). It owns more than 3, 000 hospitals in China and provides information systems to hospitals and clinics serving over 30 million people.
SHL Telemedicine is developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community.SHL Telemedicine, jointly managed by Erez Alroy and Yariv Alroy, is traded in Switzerland. The company said that its shareholders would receive 10.5 Swiss francs for each share held, a price that represents a 13% premium over the company’s closing price on Friday.
Shanghai Jiuchuan says that it sees SHL Telemedicine as a strategic investment representing a platform for penetrating the Chinese market through the leading company in its field in the world.
Read more about: Alroy,
Business/Finance,
cardiovascular and related diseases,
Erez Alroy,
Health,
Health informatics,
Health/Medical/Pharmaceuticals,
information systems,
Medical informatics,
Medicine in China,
SHANGHAI JIUCHUAN INVEST CO,
Telehealth,
Telemedicine,
Yariv Alroy
